FDAnews Device Daily Bulletin
Medical Devices / Regulatory Affairs

FDA Clears Flashback Technologies’ Compulsory Reserve Index Application

Jan. 6, 2017
A A

Flashback Technologies received de novo clearance from the FDA to market its Compulsory Reserve Index as an adjunctive cardiovascular status indicator to measure blood volume.

The algorithmic application uses optics to detect volumetric changes and provide real-time measurements of blood volume tolerance. The noninvasive tool gauges the ability to tolerant volume changes such as blood loss.

View today's stories